Leveragen Strengthens Singularity Platform IP with Australian Patent Grant

Leveragen, Inc., a Boston-based biotechnology company advancing in vivo antibody discovery, today announced the grant of Australian Patent No. 2022271276...

September 10, 2026 | Thursday | News
Intellia Therapeutics’ Lonvo-z Wins FDA Priority Review for One-Time HAE Treatment

FDA sets Prescription Drug User Fee Act (PDUFA) date of March 10, 2027 Positions lonvo-z to be the world’s first in vivo CRISPR-based therapy an...

September 10, 2026 | Thursday | News
Making Earlier Cancer Detection a Reality Through Blood-Based Diagnostics

    Early detection remains one of the biggest challenges in cancer care, particularly for ovarian cancer, where symptoms can be difficult to r...

September 09, 2026 | Wednesday | Interaction
Mabwell Reports Positive Phase Ib/IIa Results for Anti-ST2 Antibody 9MW1911 in COPD

Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the Phase Ib/IIa clinical results of its anti-S...

September 07, 2026 | Monday | News
Lupin Receives U.S. FDA Approval for Modafinil Tablets to Treat Excessive Sleepiness

Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced that it has received appro...

September 07, 2026 | Monday | News
Ono Pharma Partners With Aitia to Discover New Neurological Disease Targets Using Causal AI

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) announced that it has entered into a drug ...

September 03, 2026 | Thursday | News
IDT Expands Partnership With Ansa to Broaden Global Access to Complex DNA Synthesis

Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis...

September 03, 2026 | Thursday | News
Telix Completes BiPASS Phase 3 Enrollment, Advances PSMA-PET Imaging for Earlier Prostate Cancer Diagnosis

Telix Pharmaceuticals Limited announced completion of patient enrollment in the Phase 3 BiPASS™ study of its commercial PSMA-PET imaging agent...

September 03, 2026 | Thursday | News
Teva and Trump Administration Commit to Lowering Costs of Select Medicines for U.S. Medicaid Patients

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a shared commitment with the Trump Administration to lower the cost...

September 02, 2026 | Wednesday | News
Eisai and Biogen’s LEQEMBI Gains Canada Recommendation for Public Reimbursement in Early Alzheimer’s Disease

Eisai Co., Ltd. and Biogen Inc., announced that Canada’s Drug Agency (CDA-AMC) has issued a final recommendation supporting public reimbursement of...

September 02, 2026 | Wednesday | News
Takeda Wins FDA Approval for MIMRYLO™, First-in-Class Therapy for Polycythemia Vera

Takeda (TSE:4502/NYSE:TAK) announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) ...

September 01, 2026 | Tuesday | News
Leios Therapeutics Grants CMS Exclusive China Rights to 10XB-101 for Focal Fat Reduction

10XB-101 is a Novel Potential Best-in-Class Injectable Drug Being Developed for Focal Fat Reduction and Body Contouring  Second Major Regional Lice...

September 01, 2026 | Tuesday | News
Evonik Invests CAD 150 Million in New GMP Lipid-Based Drug Manufacturing Facility in Vancouver

Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evoni...

August 31, 2026 | Monday | News
Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer

Revolution Medicines, Inc., a global commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patie...

August 28, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close